MTOR and cancer: In addition to directly regulating the expression of glycolytic enzymes and components of the ETC, p53 can repress glycolysis by inhibiting the AKT/mTOR and NF-kB signalling pathways whose activity is strongly up-regulated in cancer cells [48],[49].